T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.16B |
| 2 |
GE Aerospace
GE
|
+$1.93B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.62B |
| 4 |
Eli Lilly
LLY
|
+$1.59B |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.72B |
| 2 |
Booking.com
BKNG
|
+$2.61B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.62B |
| 4 |
JPMorgan Chase
JPM
|
+$1.43B |
| 5 |
State Street
STT
|
+$1.29B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.46% |
| 2 | Technology | 17.53% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 14.02% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Krystal Biotech
KRYS
$9.72B
| $6.31M | ﹤0.01% |
+303,520
| New | +$6.35M |
|
|
BIG
1377
DELISTED
Big Lots, Inc.
BIG
| $6.24M | ﹤0.01% |
215,799
-208,129
| -49% | -$8.09M |
|
1378
Berkshire Hathaway Class A
BRK.A
$1.09T
| $6.12M | ﹤0.01% |
20
| – | – |
|
|
STAY
1379
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $6.09M | ﹤0.01% |
393,103
+24,820
| +7% | +$437K |
|
1380
ManpowerGroup
MAN
$2.75B
| $5.94M | ﹤0.01% |
91,698
+90
| +0.1% | +$6.84K |
|
1381
RB Global
RBA
$16B
| $5.93M | ﹤0.01% |
181,314
+1,314
| +0.7% | +$44.2K |
|
1382
iRhythm Holdings
IRTC
$4.06B
| $5.89M | ﹤0.01% |
84,792
+340
| +0.4% | +$25.8K |
|
1383
Under Armour
UAA
$2.3B
| $5.82M | ﹤0.01% |
329,502
+22,100
| +7% | +$454K |
|
1384
Forte Biosciences
FBRX
$1.57B
| $5.73M | ﹤0.01% |
1,861
+381
| +26% | +$1.64M |
|
|
CLDR
1385
DELISTED
Cloudera, Inc.
CLDR
| $5.69M | ﹤0.01% |
514,623
-55,797
| -10% | -$742K |
|
|
MIME
1386
DELISTED
Mimecast Limited
MIME
| $5.58M | ﹤0.01% |
+165,987
| New | +$5.79M |
|
|
PATI
1387
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
| $5.54M | ﹤0.01% |
284,303
-1,200
| -0.4% | -$23.9K |
|
|
CETV
1388
DELISTED
Central European Media Enterprises Ltd
CETV
| $5.48M | ﹤0.01% |
1,970,801
+170
| +0% | +$560 |
|
1389
Kinsale Capital Group
KNSL
$8.59B
| $5.44M | ﹤0.01% |
97,900
-233,564
| -70% | -$13.8M |
|
1390
iShares Core S&P 500 ETF
IVV
$910B
| $5.32M | ﹤0.01% |
21,159
+7,273
| +52% | +$1.98M |
|
|
NEWR
1391
DELISTED
New Relic, Inc.
NEWR
| $5.29M | ﹤0.01% |
65,320
-44,623
| -41% | -$3.76M |
|
|
CRZO
1392
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $5.29M | ﹤0.01% |
468,416
+9,257
| +2% | +$165K |
|
|
ODT
1393
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $5.2M | ﹤0.01% |
369,625
+118,954
| +47% | +$1.85M |
|
1394
Jack in the Box
JACK
$358M
| $5.19M | ﹤0.01% |
66,889
+979
| +1% | +$79.6K |
|
1395
UGI
UGI
$7.56B
| $5.18M | ﹤0.01% |
97,033
+4,794
| +5% | +$266K |
|
1396
Novavax
NVAX
$1.34B
| $5.17M | ﹤0.01% |
+140,542
| New | +$5.45M |
|
1397
Yext
YEXT
$613M
| $5.16M | ﹤0.01% |
347,147
-354,303
| -51% | -$6.25M |
|
1398
Royal Gold
RGLD
$19.1B
| $5.12M | ﹤0.01% |
59,826
-113,405
| -65% | -$8.73M |
|
1399
Spotify
SPOT
$102B
| $5.12M | ﹤0.01% |
45,149
+7,735
| +21% | +$1.08M |
|
|
HTGM
1400
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $5.08M | ﹤0.01% |
11,106
-2
| -0% | -$1.24K |
|
Similar funds
T. Rowe Price Associates's Q4 2018 Portfolio in Review
As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
- T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
- T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
- T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
- T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.
Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.